- A PRODUCT TRANSFER IS ALSO UNDERWAY WITH BHARAT BIOTECH OF INDIA, WHICH WILL BECOME THE SOLE SUPPLIER OF RTS,S/AS01E VACCINE IN 2029
* GSK - GSK WILL CONTINUE TO SUPPLY ADJUVANT (AS01E) TO BHARAT
https://www.marketscreener.com/quote/stock/GLAXOSMITHKLINE-PLC-9590199/news/Gsk-Says-Product-Transfer-For-Malaria-Vaccine-Underway-With-Bharat-Biotech-Of-India-37196906/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.